Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
PERFALGAN 10 mg/ml, solution for infusion - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
08/07/2010
Problem Or Issue:
Important safety information communication from Bristol-Myers Squibb Pharmaceuticals on serious cases of overdose reported in infants and children with PERFALGAN
®
10 mg/ml, solution for infusion.
Important Safety Information - PERFALGAN 10 mg/ml, solution for infusion
« Back
Date Printed: 09/08/2022